The Concept of the Central Strategic Program - Innovative Medicines

Wiesław Szelejewski 

Pharmaceutical Research Institute, Rydygiera 8, Warszawa 01-793, Poland

Abstract

[Abstract body is empty now.]

 

Related papers
  1. Polimorphism of Active Pharmaceutical Ingredients
  2. CAN A QUEST FOR A NEW DRUG OF POLISH ORIGIN BE SUCCESSFUL?
  3. ROPINIROL - GENERIC DRUG FOR PARKINSON'S DISEASE
  4. SYNTHESIS OF PIOGLITAZONE HYDROCHLORIDE OF PHARMACEUTICAL PURITY AT SMALL PLANT SCALE
  5. NEW IMPROVED METHOD OF POLYMORPHIC α FORM OF IMATINIB MESYLATE (GLEEVEC®) SYNTHESIS.
  6. NEW SYNTHESIS OF 11-(1-PIPERAZINYL)- DIBENZO[b,f][1,4]THIAZEPINE, A CRUCIAL INTERMEDIATE IN QUETIAPINE PRODUCTION.

Presentation: Invited oral at VI Multidyscyplinarna Konferencja Nauki o Leku, by Wiesław Szelejewski
See On-line Journal of VI Multidyscyplinarna Konferencja Nauki o Leku

Submitted: 2008-04-29 22:51
Revised:   2008-04-29 23:04
Google
 
Web science24.com
© 1998-2009 pielaszek research, all rights reserved Powered by the Conference Engine